Results 121 to 130 of about 4,048 (209)

Anthracycline-containing versus anthracycline-free carboplatin-based regimens in early-stage triple-negative breast cancer: real-world outcomes. [PDF]

Breast Cancer Res Treat
Kroll MR, Schroeder MC, Neuner JM, Viyyuri BR, Ravindra A, McDougall D, Chapman CG, Fleege NMG, Chrischilles EA, Song X, Phadke S.   +10 more
europepmc   +1 more source

Trisoxazole Macrolides Potentiate the Microtubule Assembly and Antimitotic Activities of Taxanes. [PDF]

Angew Chem Int Ed Engl
Ebihara S, Takaiso R, Kawaguchi S, Oshima A, Kita M.   +4 more
europepmc   +1 more source

Reimbursement for taxoids in the Netherlands

Annals of Oncology, 1997
openaire   +1 more source

Pathologic Complete Response (pCR) Rate and Predictors of Response to Taxane, Trastuzumab, and Pertuzumab in HER2‑Positive Breast Cancer: Secondary Analyses of EA1181/CompassHER2 pCR. [PDF]

J Clin Oncol
Tung N, Zhao F, DeMichele A, Prat A, Prat A, Winer EP, Wright JL, Recht A, Weiss AC, Tjoe JA, Feldman SM, Rocque GB, Smith ML, O'Sullivan CC, Sardesai SD, Tang SC, Modi S, Irvin WJ, Unni N, Battelli C, Bagegni N, Krie AK, George MA, Telli ML, Borges VF, D'Abreo N, Shah P, Villagrasa P, Badve S, Partridge AH, Miller KD, Carey LA, Wolff AC.   +32 more
europepmc   +1 more source

A retrospective analysis of taxane-based chemotherapy in small bowel adenocarcinoma. [PDF]

Oncologist
Lim M, Grandhi N, Shah P, Raghav K, Serpas V, Morelli MP, Pedersen K, Kalyan A, Salem M, Huey R, Shen JP, Wang H, Wang H, Vinocha A, Thomas J, Wolff R, Overman MJ.   +16 more
europepmc   +1 more source

Treatment Patterns and Attrition in Metastatic Castration-Resistant Prostate Cancer.

JAMA Netw Open
Hooper G, Jo Y, Nandakumar V, Gebrael G, Ozay ZI, Ostrowski M, Hardy T, Lin E, Campbell P, Murdock EG, Upadhyay L, Goel K, Thomas VM, Li H, Sokolova AO, Swami U, Agarwal N.   +16 more
europepmc   +1 more source

Acute effects of taxanes on sub-tissue fluid proportions in patients with breast cancer who underwent taxane-based chemotherapy. [PDF]

Support Care Cancer
Tuğral A, Bakar Y, Akyol M.
europepmc   +1 more source

Dose-dense adjuvant chemotherapy in HER2-low breast cancer: An exploratory analysis of the GIM2 trial. [PDF]

Breast
Molinelli C, Delucchi V, Blondeaux E, Boni L, Poggio F, Soldato D, Antonj L, Arpino G, Nisticò C, Fabi A, De Laurentiis M, Buono G, Puglisi F, Nader-Marta G, Fozza A, Pitto F, Boncore F, Cardinali B, Fregatti P, Lambertini M, Del Mastro L.   +20 more
europepmc   +1 more source

Fungal endophytes of Taxus species and regulatory effect of two strains on taxol synthesis. [PDF]

BMC Microbiol
Zhang H, Lin W, Ma R, Zang Y, Hou K, Xu Z, Xi X, Zhang W, Tang S, Liang X, Sun Y, Shen C.   +11 more
europepmc   +1 more source

A phase I/II trial of concurrent chemo-hormonal enzalutamide and cabazitaxel in patients with metastatic castration-resistant prostate cancer. [PDF]

Oncologist
Graff JN, Smith CEP, Sokolova AO, Qian DZ, Beer TM, Latour E, Bailey S, Kreitner D, Grivas P, Schweizer MT, Higano CS, Alumkal JJ, Vuky J, Yu EY, Cheng HH.   +14 more
europepmc   +1 more source